Effects of pantoprazole on systemic and gastric pro-and anti-inflammatory cytokines in critically ill patients

Iranian Journal of Pharmaceutical Research

Volumn 11, Issue 4, 2012, Pages 1051-1058

  Tabeefar, Hamed ^a   Beigmohammadi, Mohammad Taghi ^b   Javadi, Mohammad Reza ^a   Abdollahi, Mohammad ^c   Mahmoodpoor, Ata ^d   Ahmadi, Arezoo ^b   Honarmand, Hooshyar ^a   Najaf, Atabak ^b   Mojtahedzadeh, Mojtaba ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Critically ill patients; Cytokines; Pantoprazole; Stress related mucosal damage prophylaxis

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PANTOPRAZOLE; RANITIDINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ENZYME IMMUNOASSAY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SURGERY; HUMAN; INJURY; MALE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; RISK FACTOR; SEPSIS; SHOCK; STOMACH PH; STRESS ULCER;

EID: 84871349838     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Zuckerman GR and Shuman R. Therapeutic goals and treatment options for prevention of stress ulcer syndrome. Am. J. Med. (1987) 83: 29-35.
2. Schuster DP, Rowley H, Feinstein S, McGue MK and Zuckerman GR. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am. J. Med. (1984) 76: 623-630.
3. Sesler JM. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis. AACN adv. Crit. Care (2007) 18: 119.
4. Martindale RG. Contemporary strategies for the prevention of stress-related mucosal bleeding. Am. J. Health-System Pharm. (2005) 62: S11.
5. Mutlu GM, Mutlu EA and Factor P. GI Complications in patients receiving mechanical ventilation. Chest (2001) 119: 1222.
6. Meyer TA, Wang J, Tiao GM, Ogle CK, Fischer JE and Hasselgren PO. Sepsis and endotoxemia stimulate intestinal interleukin-6 production. Surgery (1995) 118: 336-342.
7. Mester M, Tompkins RG, Gelfand JA, Dinarello CA, Burke JF and Clark BD. Intestinal production of interleukin-1 [alpha] during endotoxemia in the mouse. J. Surg. Res. (1993) 54: 584-591.
8. Roumen RMH, Redl H, Schlag G, Zilow G, Sandtner W, Koller W, Hendriks T and Goris RJA. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit. Care Med. (1995) 23: 474.
9. Tamion F, Richard V, Sauger F, Menard JF, Girault C, Richard JC, Thuillez C, Leroy J and Bonmarchand G. Gastric mucosal acidosis and cytokine release in patients with septic shock. Crit. Care Med. (2003) 31: 2137.
10. Hamishehkar H, Beigmohammadi MT, Abdollahi M, Ahmadi A, Mahmoodpour A, Mirjalili MR, Abrishami R, Khoshayand MR, Eslami K and Kanani M. Identifcation of enhanced cytokine generation following sepsis. Dream of magic bullet for mortality prediction and therapeutic evaluation. DARU J. Pharm. Sci. (2010) 18: 155-162.
11. Donati A, Battisti D, Conti G, Caporelli S, Adrario E, Pelaia P, Recchioni A, Paoletti P and Pietropaoli P. Predictive value of interleukin 6 (IL-6), interleukin 8 (IL-8) and gastric intramucosal pH (pH-i) in major abdominal surgery. Intens. Care Med. (1998) 24: 329-335.
12. Mojtahedzadeh M, Rastegarpanah M, Malekzadeh R, Khalili H, Ganji MR and Gholami K. A comparative study of bolus administration and continuous infusion of ranitidine on gastric pH with intragastric pH-probe. DARU J. Pharm. Sci. (2002) 10: 153-157.
13. Azevedo JR, Soares MG, Silva G and Palacio G. Prevention of sress ulcer bleeding in high risk patients. Comparison of three drugs. Critical Care Med. (1999) 27: A145.
14. Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffth L, McLellan A, Wood G, Kirby A, Tweeddale M, Pagliarello J and Johnston R. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. New Eng. J. Med. (1998) 338: 791-797.
15. Levy MJ, Seelig CB, Robinson NJ and Ranney JE. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig. Dis. Sci. (1997) 42: 1255-1259.
16. Baghaie AA, Mojtahedzadeh M, Levine RL, Fromm Robert Jr E, Guntupalli KK and Opekun Jr A. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study. Crit. Care Med. (1995) 23: 687.
17. Shuman RB, Schuster DP and Zuckerman GR. Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann. Internal Med. (1987) 106: 562.
18. Basso N, Bagarani M, Materia A, Fiorani S, Lunardi P and Speranza V. Cimetidine and antacid prophylaxis of acute upper gastrointestinal bleeding in high risk patients: controlled, randomized trial. Am. J. Sur. (1981) 141: 339-341.
19. Priebe HJ and Skillman JJ. Methods of prophylaxis in stress ulcer disease. World J. Surg. (1981) 5: 223-229.
20. Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E and Banerjee R.K. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J. Biol. Chem. (2003) 278: 10993.
21. Ichikawa H, Yoshida N, Takagi T, Tomatsuri N, Katada K, Isozaki Y, Uchiyama K, Naito Y, Okanoue T and Yoshikawa T. Lansoprazole ameliorate intestinal mucosal damage induced by ischemia-reperfusion in rats. World J. Gastroenterol. (2004) 10: 2814-2817.
22. Handa O, Yoshida N, Fujita N, Tanaka Y, Ueda M, Takagi T, Kokura S, Naito Y, Okanoue T and Yoshikawa T. Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflammation Res. (2006) 55: 476-480.
23. Sasaki T, Yamaya M, Yasuda H, Inoue D, Yamada M, Kubo H, Nishimura H and Sasaki H. The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells. Eur. J. Pharmacol. (2005) 509: 201-210.
24. Smith WB, Gamble JR, Clark-Lewis I and Vadas MA. Interleukin-8 induces neutrophil transendothelial migration. Immunology (1991) 72: 65.
25. Suzuki M, Suzuki H, Kitahora T, Miyazawa M, Nagahashi S, Suzuki K and Ishii H. Proton pump inhibitor modifes inflammatory reaction in human gastric mucosa infected by Helicobacter pylori. Aliment. Pharmacol. Ther. (2002) 16: 229-234.
26. Naito Y, Takagi T and Yoshikawa T. Lansoprazole, a proton pump inhibitor, to reduce gastrointestinal inflammation via heme oxygenase-1 induction. Mol. Cell. Pharmacol. (2010) 2: 53-60.
27. Namazi MR and Jowkar F. A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors. J. Clin. Pharm. Ther. (2008) 33: 215-217.
28. Kedika RR, Souza RF and Spechler SJ. Potential anti- inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig. Dis. Sci. (2009) 54: 2312-2317.
29. Hinoki A, Yoshimura K, Fujita K, Akita M, Ikeda R, Nagashima M, Nomura M and Satomi A. Suppression of proinflammatory cytokine production in macrophages by lansoprazole. Ped. Surg. Int. (2006) 22: 915-923.
30. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y and Oshitani N. Lansoprazole, a proton pump inhibitor, suppresses production of tumor necrosis factor- and interleukin-1 induced by lipopolysaccharide and Helicobacter pylori bacterial components in human monocytic cells via inhibition of activation of nuclear factor- B and extracellular signal-regulated kinase. J. Clin. Biochem. Nutr. (2009) 45: 86.
31. Zingarelli B, Yang Z, Hake PW, Denenberg A and Wong HR. Absence of endogenous interleukin 10 enhance early stress response during post-ischaemic injury in mice intestine. Gut (2001) 48: 610.
32. Seare NJ and Playford RJ. Growth factors and gut function. Proceed. Nutr. Soc. (1998) 57: 403-408.
33. Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffth L, McLellan A, Wood G, Kirby A, Tweeddale M, Pagliarello J and Johnston R. A Comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. New Eng. J. Med. (1998) 338: 791-797.
34. Levy MJ, Seelig CB, Robinson NJ and Ranney JE. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig. Dis. Sci. (1997) 42: 1255-1259.